Phase I/II Trial of Perioperative Avelumab in Combination With Chemoradiation in the Treatment of Stage II/III Resectable Esophageal and Gastroesophageal Junction Cancer. - Uboha NV; Basree MM; Eickhoff JC; Deming DA; Matkowskyj K; Maloney J; McCarthy D; DeCamp M; LoConte N; Emmerich PB; Kraus S; Patel MA; et al. (Journal of surgical oncology, 2025)